Search Results Search Sort by RelevanceMost Recent Viewpoint Jan 2006 Is Prenatal Genetic Screening Unjustly Discriminatory? Jeff McMahan, PhD Virtual Mentor. 2006;8(1):50-52. doi: 10.1001/virtualmentor.2006.8.1.oped1-0601. Viewpoint Jan 2006 The Uncertain Rationale for Prenatal Disability Screening David Wasserman, JD and Adrienne Asch, PhD Virtual Mentor. 2006;8(1):53-56. doi: 10.1001/virtualmentor.2006.8.1.oped2-0601. State of the Art and Science Apr 2005 Complications of Anticoagulation with Heparin Mahesh Krishnamurthy, MD and Michael L. Freedman, MD Virtual Mentor. 2005;7(4):297-300. doi: 10.1001/virtualmentor.2005.7.4.cprl1-0504. State of the Art and Science Oct 2019 Should Clinicians Leave “Expanded” Carrier Screening Decisions to Patients? Amanda Fakih, MHSA and Kayte Spector-Bagdady, JD, MBE Testing everyone for everything identifies more fetal conditions, but confusion persists about whether clinicians should leave screening decisions to patients. AMA J Ethics. 2019;21(10):E858-864. doi: 10.1001/amajethics.2019.858. Medical Education Dec 2020 How Educators Can Help Prevent False Brain Death Diagnoses Farah Fourcand, MD and Diana M. Barratt, MD, MPH For many physicians, lack of understanding about brain death leads to confusion and muddles interactions with patients’ loved ones at the end of life. AMA J Ethics. 2020;22(12):E1010-1018. doi: 10.1001/amajethics.2020.1010. Policy Forum Dec 2020 What Should We Do About the Mismatch Between Legal Criteria for Death and How Brain Death Is Diagnosed? Nathaniel M. Robbins, MD and James L. Bernat, MD Criteria in statutes and tests used to diagnose brain death don’t always jibe, and this can undermine public trust in death pronouncements. AMA J Ethics. 2020;22(12):E1038-1046. doi: 10.1001/amajethics.2020.1038.